Survodutide
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Red
Boehringer Ingelheim · Phase 3 · Completed · Enrollment 218
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Treatment arm | n/r | n/r | n/r | n/r |
| Placebo arm | n/r | n/r | n/r | n/r |
Not shown
- Treatment arm: endpoint not reported
- Placebo arm: endpoint not reported